CTOs on the Move

Laboratory Corporation

www.labcorp.com

 
LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of more than $10 billion in 2017.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.labcorp.com
  • 531 South Spring Street
    Burlington, NC USA 27215
  • Phone: 336.229.1127

Executives

Name Title Contact Details
Walt Lehman
Director, IT Sourcing Profile
Mark Sausen
Head of Technology Innovation, PGDx Profile
Lance Berberian
Chief Information Officer Profile
Lidia Fonseca
Chief Information Officer Profile

Funding

Laboratory Corporation raised $850M on 06/04/2019

Similar Companies

Nanogen

Nanogen, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celsus Laboratories

Celsus Laboratories is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diagnostic Clinic of Houston

At Diagnostic Clinic, our philosphy is driven by a desire to create a physician-patient relationship that is centered on trust. While many beliefs shift with time, some should never go out of style. Diagnostic Clinic has held true to its founders' basic

Natera

Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a safe, simple test for pregnant women that identifies the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Natera's PreNATUS clinical trial for non-invasive screening of fetal chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. These tests were developed by Natera, a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). In August, Natera was selected by the World Economic Forum as a Technology Pioneer for innovations in prenatal care. For more information, visit www.natera.com.

Ctlabs

Ctlabs is a Rocklin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.